Academic Journal
Q1International Journal of Alzheimer’s Disease
About International Journal of Alzheimer’s Disease
About International Journal of Alzheimer’s Disease
International Journal of Alzheimer’s Disease is a peer-reviewed scholarly journal published by John Wiley and Sons Ltd (United States). It focuses on Q1. Publication coverage spans 2009-2024.
Key indicators: ISSN 2090-8024, 2090-0252; H-index 68.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (68): Strong citation impact — 68 articles cited at least 68 times each, reflecting solid influence.
Publishing in International Journal of Alzheimer’s Disease
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of International Journal of Alzheimer’s Disease?
2090-8024, 2090-0252.
Who publishes International Journal of Alzheimer’s Disease?
John Wiley and Sons Ltd.
What are International Journal of Alzheimer’s Disease's metrics?
H-index 68.
Where do I submit to International Journal of Alzheimer’s Disease?
Via the official website.
Is International Journal of Alzheimer’s Disease peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
Alzheimer's disease research and treatments; Dementia and Cognitive Impairment Research; Cholinesterase and Neurodegenerative Diseases; Computational Drug Discovery Methods; Neuroinflammation and Neurodegeneration Mechanisms; Functional Brain Connectivity Studies.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
820.00 USD
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Novel Biomarkers for Alzheimer’s Disease: Plasma Neurofilament Light and Cerebrospinal Fluid
Daniel Naawenkangua Abukuri
2024-05-15 · DOI: 10.1155/2024/6668159In Silico Investigation of Novel Compounds as Inhibitors of Acetylcholinesterase Enzyme for the Treatment of Alzheimer’s Diseases
Kassim Adebambo, Oghenekevwe (Claudia) Ojoh
2024-02-08 · DOI: 10.1155/2024/2988685Advancements and Challenges in Antiamyloid Therapy for Alzheimer’s Disease: A Comprehensive Review
Semira Abdi Beshir, Nadia Hussain, Vineetha Bharathan Menon, Amal H. I. Al Haddad et al.
2024-01 · DOI: 10.1155/2024/2052142Inflammatory Manifestations Associated With Gut Dysbiosis in Alzheimer’s Disease
Samat Kozhakhmetov, Aiym Kaiyrlykyzy, Zharkyn Jarmukhanov, Elizaveta Vinogradova et al.
2024-01 · DOI: 10.1155/2024/9741811Unveiling Neuroprotective Potential of Spice Plant-Derived Compounds against Alzheimer’s Disease: Insights from Computational Studies
Md. Murshid Alom, Rejwana Parvin Bonna, Ariful Islam, Md. Wasim Alom et al.
2023-09-15 · DOI: 10.1155/2023/8877757Prognosis of Biomarker of Alzheimer’s Disease in the Function of the Retina and Secondary Molecular Structure Variation of the Retina and Brain
Heba Ahmed Gaber, Eman Mohamed Aly, Eman Saad Mohamed, Marwa Elfouly et al.
2023-03-29 · DOI: 10.1155/2023/9775921A Comprehensive Investigation of the Potential Role of Lipoproteins and Metabolite Profile as Biomarkers of Alzheimer’s Disease Compared to the Known CSF Biomarkers
Azam Sajjadi Nasab, Fatemeh Noorani, Zahra Paeizi, Leila Khani et al.
2023-03-09 · DOI: 10.1155/2023/3540020Cyclic Glycine-Proline Improves Memory and Reduces Amyloid Plaque Load in APP/PS1 Transgenic Mouse Model of Alzheimer’s Disease
Tushar Arora, Shiv K. Sharma
2023-03-01 · DOI: 10.1155/2023/1753791CSF-Targeted Proteomics Indicate Amyloid-Beta Ratios in Patients with Alzheimer’s Dementia Spectrum
Maryam Behzad, Negin Zirak, Ghazal Hamidi Madani, Linda Baidoo et al.
2023-02-06 · DOI: 10.1155/2023/5336273Trends in Healthcare Resource Use Preceding Diagnosis of Alzheimer’s Disease Dementia
Ibrahim M. Abbass, Dae Choi, Christopher Wallick, Sheila Seleri Assunção et al.
2023-01-07 · DOI: 10.1155/2023/8154701Multimer Detection System-Oligomerized Amyloid Beta (MDS-OAβ): A Plasma-Based Biomarker Differentiates Alzheimer’s Disease from Other Etiologies of Dementia
Jacqueline Cotoong Dominguez, Jeryl Ritzi Tan Yu, Ma Fe De Guzman, Encarnita Ampil et al.
2022-05-02 · DOI: 10.1155/2022/9960832Aducanumab Therapy to Treat Alzheimer’s Disease: A Narrative Review
Semira Abdi Beshir, A. M. Aadithsoorya, Affana Parveen, Sheron Sir Loon Goh et al.
2022-03-09 · DOI: 10.1155/2022/9343514Coresidence of Older Parents and Adult Children Increases Older Adults’ Self-Reported Psychological Well-Being
Soohyoung Rain Lee, Laurie S. Kim
2022-01-27 · DOI: 10.1155/2022/5406196Validation of AD8-Philippines (AD8-P): A Brief Informant-Based Questionnaire for Dementia Screening in the Philippines
Jacqueline C. Dominguez, Ma. Fe P. de Guzman, Ma. Lourdes C. Joson, Krizelle Fowler et al.
2021-10-31 · DOI: 10.1155/2021/7750235The Genetic Research in Alzheimer Disease (GERALD) Initiative Finds rs9320913 as a Neural eQTL of lincRNA AL589740.1
Lidia Lopez-Gutierrez, José María García-Alberca, Silvia Mendoza, Esther Gris et al.
2021-09-03 · DOI: 10.1155/2021/3064224Modifying the Mini-Cog to Screen for Cognitive Impairment in Nonliterate Individuals
Shambhu P. Adhikari, Rubee Dev, Soo Borson
2021-08-16 · DOI: 10.1155/2021/5510093Improving the Quality of Life of Family Caregivers of People with Alzheimer’s Disease through Virtual Communities of Practice: A Quasiexperimental Study
Montse Romero-Mas, Anna Ramon-Aribau, Dyego Leandro Bezerra de Souza, Andrew M. Cox et al.
2021-04-05 · DOI: 10.1155/2021/8817491Current State of Non-wearable Sensor Technologies for Monitoring Activity Patterns to Detect Symptoms of Mild Cognitive Impairment to Alzheimer’s Disease
Rajaram Narasimhan, Muthukumaran G., Charles McGlade
2021-02-10 · DOI: 10.1155/2021/2679398Structural Brain Imaging Phenotypes of Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD) Found by Hierarchical Clustering
Mikko Kärkkäinen, Mithilesh Prakash, Marzieh Zare, Jussi Tohka et al.
2020-11-13 · DOI: 10.1155/2020/2142854Reviews
Community Reviews
Version History
October 9, 2026 at 7:12 pm
September 25, 2026